Difficulty: Medium
Average Score: 89%
Practice
The most frequent drug interaction in patients using sedative hypnotics is
Correct answer
A
Rationale
In patients using sedative-hypnotic drugs, the most frequent drug interaction is an additive CNS depression (Option A). This occurs because sedative-hypnotics already depress the central nervous system (CNS), and when combined with other CNS depressants like alcohol or opioids, the effects can be potentiated, leading to excessive sedation, respiratory depression, and even coma.
Option B, antagonism of sedative or hypnotic actions, is less likely to occur because drug interactions typically lead to additive effects rather than cancelling each other out. Option C, competition for plasma protein binding, is a common type of drug interaction but is not the most frequent one seen with sedative-hypnotics. Option D, induction of liver drug-metabolizing enzymes, can lead to decreased levels of sedative-hypnotics in the body, but it is not the most common interaction observed with these drugs.
Educationally, understanding drug interactions is crucial for healthcare professionals to ensure safe and effective medication management. In the case of CNS drugs, the potential for additive CNS depression highlights the importance of cautious prescribing, monitoring for signs of sedation, and educating patients on the risks of combining sedative-hypnotics with other CNS depressants. This knowledge is vital for pharmacists, nurses, and physicians to prevent adverse drug events and optimize patient care.
Option B, antagonism of sedative or hypnotic actions, is less likely to occur because drug interactions typically lead to additive effects rather than cancelling each other out. Option C, competition for plasma protein binding, is a common type of drug interaction but is not the most frequent one seen with sedative-hypnotics. Option D, induction of liver drug-metabolizing enzymes, can lead to decreased levels of sedative-hypnotics in the body, but it is not the most common interaction observed with these drugs.
Educationally, understanding drug interactions is crucial for healthcare professionals to ensure safe and effective medication management. In the case of CNS drugs, the potential for additive CNS depression highlights the importance of cautious prescribing, monitoring for signs of sedation, and educating patients on the risks of combining sedative-hypnotics with other CNS depressants. This knowledge is vital for pharmacists, nurses, and physicians to prevent adverse drug events and optimize patient care.